These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6296868)

  • 1. 1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells.
    Honma Y; Hozumi M; Abe E; Konno K; Fukushima M; Hata S; Nishii Y; DeLuca HF; Suda T
    Proc Natl Acad Sci U S A; 1983 Jan; 80(1):201-4. PubMed ID: 6296868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies.
    Kasukabe T; Honma Y; Hozumi M; Suda T; Nishii Y
    Cancer Res; 1987 Jan; 47(2):567-72. PubMed ID: 3466692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice.
    Zhou JY; Norman AW; Chen DL; Sun GW; Uskokovic M; Koeffler HP
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3929-32. PubMed ID: 2339131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels.
    Pakkala S; de Vos S; Elstner E; Rude RK; Uskokovic M; Binderup L; Koeffler HP
    Leuk Res; 1995 Jan; 19(1):65-72. PubMed ID: 7837819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D metabolism in pregnant rabbits: differences between the maternal and fetal response to administration of large amounts of vitamin D3.
    Kubota M; Ohno J; Shiina Y; Suda T
    Endocrinology; 1982 Jun; 110(6):1950-6. PubMed ID: 6280980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular calcium is involved in the mechanism of differentiation of mouse myeloid leukemia cells (M1) induced by 1 alpha, 25-dihydroxyvitamin D3.
    Miyaura C; Abe E; Suda T
    Endocrinology; 1984 Nov; 115(5):1891-6. PubMed ID: 6548439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic analogue of vitamin D3, 22-oxa-1 alpha,25-dihydroxyvitamin D3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice.
    Abe J; Takita Y; Nakano T; Miyaura C; Suda T; Nishii Y
    Endocrinology; 1989 May; 124(5):2645-7. PubMed ID: 2539984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperative effect of 1 alpha,25-dihydroxyvitamin D3 and dexamethasone in inducing differentiation of mouse myeloid leukemia cells.
    Miyaura C; Abe E; Honma Y; Hozumi M; Nishii Y; Suda T
    Arch Biochem Biophys; 1983 Dec; 227(2):379-85. PubMed ID: 6582801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of postmenopausal osteoporosis with active vitamin D3, 1-alpha-hydroxycholecalciferol (1 alpha-OHD3) and 1, 24 Dihydroxycholecalciferol (1, 24(OH)2D3).
    Shiraki M; Orimo H; Ito H; Akiguchi I; Nakao J; Takahashi R; Ishizuka S
    Endocrinol Jpn; 1985 Apr; 32(2):305-15. PubMed ID: 2995014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
    Norman AW; Zhou JY; Henry HL; Uskokovic MR; Koeffler HP
    Cancer Res; 1990 Nov; 50(21):6857-64. PubMed ID: 2208153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating and antitumor activities of 1 alpha,25-dihydroxyvitamin D3 in vitro and 1 alpha-hydroxyvitamin D3 in vivo on human osteosarcoma.
    Tsuchiya H; Morishita H; Tomita K; Ueda Y; Tanaka M
    J Orthop Res; 1993 Jan; 11(1):122-30. PubMed ID: 8423514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
    Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
    Chow EC; Quach HP; Vieth R; Pang KS
    Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse primary osteoblasts express vitamin D3 25-hydroxylase mRNA and convert 1 alpha-hydroxyvitamin D3 into 1 alpha,25-dihydroxyvitamin D3.
    Ichikawa F; Sato K; Nanjo M; Nishii Y; Shinki T; Takahashi N; Suda T
    Bone; 1995 Jan; 16(1):129-35. PubMed ID: 7742071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic inhibition of tumor promoter-induced ornithine decarboxylase in 1 alpha-hydroxyvitamin D3-treated animals.
    Hashiba H; Fukushima M; Chida K; Kuroki T
    Cancer Res; 1987 Oct; 47(19):5031-5. PubMed ID: 3621189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hypercalcemia-producing tumor on 1,25(OH)2D3 biosynthesis in athymic mice.
    Kukreja SC; York PA; Nalbantian-Brandt C; Shevrin DH; Favus MJ
    Am J Physiol; 1989 Feb; 256(2 Pt 1):E309-14. PubMed ID: 2919669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
    Voigts AL; Felsenfeld AJ; Llach F
    Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in renal slices from the rat.
    Armbrecht HJ; Zenser TV; Davis BB
    Endocrinology; 1981 Jul; 109(1):218-22. PubMed ID: 6972300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.